Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas
Yi Wang,Qing Sun,Yun Zhang,Xuelian Li,Qingtao Liang,Ru Guo,Liqun Zhang,Xiqin Han,Jing Wang,Lingling Shao,Yu Xue,Yang Yang,Hua Li,Lihui Nie,Wenhui Shi,Qiuyue Liu,Jing Zhang,Hongfei Duan,Hairong Huang,Laurence Don Wai Luu,Jun Tai,Xinting Yang,Guirong Wang
DOI: https://doi.org/10.1016/j.jinf.2023.03.020
IF: 28.2
2023-04-01
Journal of Infection
Abstract:Tuberculosis (TB), caused by Mycobacterium tuberculosis ( Mtb ) infection, is currently the deadliest infectious disease in human that can evolve to severe forms. A comprehensive immune landscape for Mtb infection is critical for achieving TB cure, especially for severe TB patients. We performed single-cell RNA transcriptome and T-cell/B-cell receptor (TCR/BCR) sequencing of 213,358 cells from 27 samples, including 6 healthy donors and 21 active TB patients with varying severity (6 mild, 6 moderate and 9 severe cases). Two published profiles of latent TB infection were integrated for the analysis. We observed an obviously elevated proportion of inflammatory immune cells (e.g., monocytes), as well as a markedly decreased abundance of various lymphocytes (e.g., NK and γδT cells) in severe patients, revealing that lymphopenia might be a prominent feature of severe disease. Further analyses indicated that significant activation of cell apoptosis pathways, including perforin/granzyme-, TNF-, FAS- and XAF1-induced apoptosis, as well as cell migration pathways might confer this reduction. The immune landscape in severe patients was characterized by widespread immune exhaustion in Th1, CD8 + T and NK cells as well as high cytotoxic state in CD8 + T and NK cells. We also discovered that myeloid cells in severe TB patients may involve in the immune paralysis. Systemic upregulation of S100A12 and TNFSF13B , mainly by monocytes in the peripheral blood, may contribute to the inflammatory cytokine storms in severe patients. Our data offered a rich resource for understanding of TB immunopathogenesis and designing effective therapeutic strategies for TB, especially for severe patients.
infectious diseases